|
15 Oct 2019 |
Replimune Provides Update on RP1 Clinical Development Program in Cutaneous Squamous Cell Carcinoma
|
|
15 Oct 2019 |
Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer
|
|
11 Oct 2019 |
Eyevensys Presents Initial Data from Phase I/II Trial of Innovative, Non-Viral Gene Therapy for Ocular Diseases at 11th Annual Ophthalmology Innovation Summit
|
|
11 Oct 2019 |
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of CAR-T Associated Neurotoxicity
|
|
11 Oct 2019 |
MolMed informs on its decision to withdraw the Conditional Marketing Authorization of Zalmoxis
|
|
10 Oct 2019 |
ProQR Announces Positive Top-Line Results from the Phase 1/2 Study of Sepofarsen in LCA10 Patients
|
|
10 Oct 2019 |
Ionis' Factor XI anti-thrombotic medicine advances with Bayer following positive clinical results
|
|
09 Oct 2019 |
City of Hope Is Enrolling Patients in First of Its Kind Clinical Trial for Brain Tumor Patients
|
|
08 Oct 2019 |
Azitra Presents Data Showing Tolerability of its Lead Product Candidate ATR-04
|
|
08 Oct 2019 |
AVROBIO Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy for Cystinosis
|
|
08 Oct 2019 |
Cabaletta Bio Announces Presentation of Preclinical Data Showing Specific CAAR T Activity against Anti-MuSK Expressing B Cells
|
|
07 Oct 2019 |
Helixmith shows long-term safety and efficacy of VM202 for painful DPN patients in DPN phase 3-1b extension study
|
|
05 Oct 2019 |
Audentes Therapeutics Presents New Positive Data from ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked Myotubular Myopathy (XLMTM), at the 24th International Annual Congress of the World Muscle Society
|
|
04 Oct 2019 |
Sarepta Therapeutics Announces Positive Functional Results from the SRP-9003 (MYO-101) Gene Therapy Trial to Treat Limb-Girdle Muscular Dystrophy Type 2E, or Beta-Sarcoglycanopathy
|
|
04 Oct 2019 |
GT Biopharma Announces HIV TriKE™ Data Demonstrating NK Cell Killing of Patient HIV Infected Cells
|
|
02 Oct 2019 |
Dynacure Presents New Preclinical Results on Muscle Targeting with Antisense Oligonucleotides at the 24th Annual International Congress of the World Muscle Society
|
|
02 Oct 2019 |
NMPA Approves IND Application for CT103A, a Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by IASO BIO and Innovent Biologics
|
|
02 Oct 2019 |
Cabaletta Bio Receives IND Clearance from FDA to Initiate First Clinical Trial of DSG3-CAART in Patients with Mucosal Pemphigus Vulgaris
|
|
02 Oct 2019 |
Ziopharm Oncology Announces FDA Clearance of IND for Rapid Personalized Manufacture of CD19-specific CAR-T
|
|
01 Oct 2019 |
Checkmate Pharmaceuticals Announces Dosing of First Patient in a Phase 1b/2 Study in Squamous Cell Carcinoma of the Head and Neck with Lead Investigational Candidate CMP-001
|
|
01 Oct 2019 |
Idera Pharmaceuticals Announces Initiation of the ILLUMINATE-206 Trial Evaluating Tilsotolimod in Combination with Nivolumab and Ipilimumab for the Treatment of Solid Tumors
|
|
01 Oct 2019 |
Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO
|
|
30 Sep 2019 |
Moderna Announces Open IND for Propionic Acidemia Program (mRNA-3927)
|
|
30 Sep 2019 |
Ocugen and CanSinoBIO Enter Strategic Partnership for Gene Therapy Co-Development and Manufacturing
|
|
27 Sep 2019 |
BioMarin, Pioneer in Phenylketonuria (PKU) Therapies, Submits Clinical Trial Application (CTA) in U.K. for Investigational Gene Therapy for PKU
|
